143 related articles for article (PubMed ID: 31036650)
1. Molecular engineering of an efficient four-domain DAF-MCP chimera reveals the presence of functional modularity in RCA proteins.
Panwar HS; Ojha H; Ghosh P; Barage SH; Raut S; Sahu A
Proc Natl Acad Sci U S A; 2019 May; 116(20):9953-9958. PubMed ID: 31036650
[TBL] [Abstract][Full Text] [Related]
2. Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein.
Ahmad M; Raut S; Pyaram K; Kamble A; Mullick J; Sahu A
J Immunol; 2010 Nov; 185(10):6128-37. PubMed ID: 20956343
[TBL] [Abstract][Full Text] [Related]
3. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
4. Identification of complement regulatory domains in vaccinia virus complement control protein.
Mullick J; Bernet J; Panse Y; Hallihosur S; Singh AK; Sahu A
J Virol; 2005 Oct; 79(19):12382-93. PubMed ID: 16160165
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of Kaposica reveals that bridging of MG2 and CUB domains of target protein is crucial for the cofactor activity of RCA proteins.
Gautam AK; Panse Y; Ghosh P; Reza MJ; Mullick J; Sahu A
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12794-9. PubMed ID: 26420870
[TBL] [Abstract][Full Text] [Related]
6. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
7. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
8. Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.
Mark L; Proctor DG; Blackbourn DJ; Blom AM; Spiller OB
Immunology; 2008 Feb; 123(2):228-38. PubMed ID: 17764451
[TBL] [Abstract][Full Text] [Related]
9. Functional properties of membrane cofactor protein of complement.
Seya T; Atkinson JP
Biochem J; 1989 Dec; 264(2):581-8. PubMed ID: 2481448
[TBL] [Abstract][Full Text] [Related]
10. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
Brodbeck WG; Mold C; Atkinson JP; Medof ME
J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
[TBL] [Abstract][Full Text] [Related]
11. Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi's sarcoma-associated herpesvirus.
Pyaram K; Kieslich CA; Yadav VN; Morikis D; Sahu A
J Immunol; 2010 Feb; 184(4):1956-67. PubMed ID: 20089702
[TBL] [Abstract][Full Text] [Related]
12. [Structure and function of a cell-associated complement regulatory protein, membrane cofactor protein (MCP)].
Seya T
Hokkaido Igaku Zasshi; 1988 Mar; 63(2):259-68. PubMed ID: 3384397
[TBL] [Abstract][Full Text] [Related]
13. Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.
Forneris F; Wu J; Xue X; Ricklin D; Lin Z; Sfyroera G; Tzekou A; Volokhina E; Granneman JC; Hauhart R; Bertram P; Liszewski MK; Atkinson JP; Lambris JD; Gros P
EMBO J; 2016 May; 35(10):1133-49. PubMed ID: 27013439
[TBL] [Abstract][Full Text] [Related]
14. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
[TBL] [Abstract][Full Text] [Related]
15. Mapping of functional domains in herpesvirus saimiri complement control protein homolog: complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activities.
Singh AK; Yadav VN; Pyaram K; Mullick J; Sahu A
J Virol; 2009 Oct; 83(19):10299-304. PubMed ID: 19640995
[TBL] [Abstract][Full Text] [Related]
16. Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors.
Krych-Goldberg M; Hauhart RE; Porzukowiak T; Atkinson JP
J Immunol; 2005 Oct; 175(7):4528-35. PubMed ID: 16177096
[TBL] [Abstract][Full Text] [Related]
17. Chimeric CD46/DAF molecules reveal a cryptic functional role for SCR1 of DAF in regulating complement activation.
Christiansen D; Loveland B; Kyriakou P; Lanteri M; Rubinstein E; Gerlier D
Mol Immunol; 2000; 37(12-13):687-96. PubMed ID: 11275254
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the active sites in decay-accelerating factor.
Kuttner-Kondo LA; Mitchell L; Hourcade DE; Medof ME
J Immunol; 2001 Aug; 167(4):2164-71. PubMed ID: 11490001
[TBL] [Abstract][Full Text] [Related]
19. The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system.
Mark L; Lee WH; Spiller OB; Proctor D; Blackbourn DJ; Villoutreix BO; Blom AM
J Biol Chem; 2004 Oct; 279(43):45093-101. PubMed ID: 15304516
[TBL] [Abstract][Full Text] [Related]
20. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
Blom AM; Kask L; Dahlbäck B
Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
